Cardiovascular composite events

1 paper1 finding

Associations

1

Finerenone

downin humans1

1 study

Finerenone lowers the risk of cardiovascular composite events in humans.
Review
Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease
Diabetes, obesity & metabolism17 Sep 2026

More on Finerenone

Latest

1 in 12 months

Diabetes, Obesity & Metabolism17 Sep

Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease

Meta-analysis of randomised trialsSGLT2 inhibitors